IsoRay

$0.365
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0021 (-0.58%) Today

+$0.0021 (+0.58%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell IsoRay and other stocks, options, and ETFs commission-free!

About ISR

IsoRay, Inc., also called IsoRay, is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. The listed name for ISR is IsoRay, Inc.

CEO

Lori A. Woods

Employees

Headquarters

Richland, Washington

Founded

1983

Market Cap

31.65M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

775.22K

High Today

$0.367

Low Today

$0.355

Open Price

$0.365

Volume

1.09M

52 Week High

$1.06

52 Week Low

$0.352

Collections

ISR Earnings

-$0.02

-$0.01

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Feb 9, After Hours